does the prognosis of colorectal cancer vary with tumor site?

نویسندگان

mohamad asghari jafarabadi phd

seyede momeneh mohammadi

ebrahim hajizadeh

anoshirvan kazemnejad

چکیده

aim : the aim of this study was to compare prognostic factors between colon and rectal cancers. background : prognosis of colorectal cancer (crc) may depend on the anatomical site. patients and methods : a total of 1219 patients with crc diagnosis according to the pathology report of rcgld cancer registry, from 1 january 2002 to 1 october 2007, were entered into the study. demographic and clinico-pathological factors were analyzed using survival analysis. results : from age at diagnosis, colon cancer had significantly better survival than rectal cancer (multivariate hazard ratio (mvhr)=0.24; 95% confidence interval (ci) =(0.074-0.77)). other factors, including marital status (mvhr =1.78; 95% ci =(0.33-9.62)), body mass index (bmi) (mvhr =1.21 and 1.54;  95% ci =(.30-4.85) and (.44-5.4) respectively for 30 bmi groups), pathologic stage (mvhr =.64; 95% ci =(.21-1.98)) and alcohol history (mvhr =4.86; 95% ci =(.67-35.14)) were not significantly different between the two patient group but suggested a possible effect upon prognosis. overall survival in rectum was better than that of colon. conclusion : our findings support this hypothesis that prognosis of crc varies with tumor site.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Does the prognosis of colorectal cancer vary with tumor site?

AIM The aim of this study was to compare prognostic factors between colon and rectal cancers. BACKGROUND Prognosis of Colorectal Cancer (CRC) may depend on the anatomical site. PATIENTS AND METHODS A total of 1219 patients with CRC diagnosis according to the pathology report of RCGLD cancer registry, from 1 January 2002 to 1 October 2007, were entered into the study. Demographic and clinico...

متن کامل

the study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region

چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...

15 صفحه اول

Evaluation of MLL2 (KMT2B) Gene Expression in Colorectal Cancer Tissue Compared with Adjacent Tumor Free Tissue

Background and Aims: An impairment of expression in MLL2 gene involved in histone methylation induces alteration in the methylation patterns at enhancers and causes several cancers including colon cancer. In this study, MLL2 expression was evaluated in North West of Iran. Materials and Methods: To evaluate the MLL2 expression in patients with colon cancer, 25 tumor samples and 25 samples of tu...

متن کامل

pathology and prognosis of colorectal cancer

abstract:   introduction: colorectal cancer (crc) is one of the most common cancers in the world. during the past decades, survival of colorectal cancer patients has improved worldwide, however, it is not clear what factors have contributed to this development. this study was designed to evaluate the prognostic impact of a wide spectrum of pathologic parameters on survival rate in patients with...

متن کامل

Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients

The development of colorectal cancer (CRC) is commonly accompanied by the overexpression of the cyclooxygenase-2 (COX-2) gene, with high levels being most common in early colorectal lesions. In the present study, we hypothesized that the expression of COX-2 in normal mucosa affects the expression of COX-2 in adjacent tumors. COX-2 protein expression levels were determined in tumor tissues and t...

متن کامل

Expression of HER2 in Colorectal Cancer Does Not Correlate with Prognosis

Estimation of HER2 membranous expression is routinely used in breast and gastric cancers, as both a prognostic and a predictive factor. To date there is no evidence for similar application of HER2 expression in colorectal cancer (CRC) cells. In CRC, HER2 is sometimes overexpressed in the cell membrane and very often in the cytoplasm. This study was conducted to determine possible correlations b...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
gastroenterology and hepatology from bed to bench

جلد ۴، شماره ۴، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023